The content on this site is intended for healthcare professionals only
Prof Daniel Hays talks to ecancer at the IMProving care And Knowledge through Translational research (IMPAKT) meeting in Brussels, May 2012 about which criteria should be met before the implementation of whole genome arrays in clinical practice.
Filming Supported by Amgen
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
The added value of integrative medicine
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Best practice in HRRm testing in patients with metastatic prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
